Table 1. Patient Clinical and Laboratory... | American Society of Hematology

Table 1.

Patient Clinical and Laboratory Characteristics and Telomerase Activity

Patients	Time (yr after SC)	CD4 (/μL)	RNA Load (log copies per mL)	Telomerase Activity		Antiviral Treatment	Viral Phenotype
				CD4	CD8
				(%)
H-1171	0.5	830	3.7	0.09	0.87		NSI
H-1171	8.0	540	3.0	0	0.09		NSI
H-658	0.1	950	6	ND	0.87		NSI
H-658	4.2	810	3	0.09	0.09		NSI
H-1024	0.1	900	5.5	0.13	1.3		NSI
H-1024	7.5	410	4.0	0.13	0.13		NSI
H-232	0.8	390	5.6	0.009	0.009		NSI
H-232	9.5	320	4.5	0.09	0.87	AZT	NSI
H-412	0.7	990	4.8	0.04	0.2		NSI
H-412	4.3	490	4.8	0.2	0.2		NSI
H-39	−1.2	1,160		0.009	0.09
H-39	2.9	230	5.9	0.09	0.87		SI
H-8317	0.7	550	5.7	0.2	0.2		NSI
H-8317	3.6	50	5.9	0.04	0.04	AZT	SI
	Mean (^*) early			0.08 (0.07)	0.51 (0.50)
	Mean (^*) late			0.09 (0.06)	0.32 (0.37)
Control 1				0.2	0.2
Control 2				0.13	0.13
Control 3				0.009	0.09
	Mean (^*)			0.11 (0.09)	0.14 (0.06)

Patients	Time (yr after SC)	CD4 (/μL)	RNA Load (log copies per mL)	Telomerase Activity		Antiviral Treatment	Viral Phenotype
				CD4	CD8
				(%)
H-1171	0.5	830	3.7	0.09	0.87		NSI
H-1171	8.0	540	3.0	0	0.09		NSI
H-658	0.1	950	6	ND	0.87		NSI
H-658	4.2	810	3	0.09	0.09		NSI
H-1024	0.1	900	5.5	0.13	1.3		NSI
H-1024	7.5	410	4.0	0.13	0.13		NSI
H-232	0.8	390	5.6	0.009	0.009		NSI
H-232	9.5	320	4.5	0.09	0.87	AZT	NSI
H-412	0.7	990	4.8	0.04	0.2		NSI
H-412	4.3	490	4.8	0.2	0.2		NSI
H-39	−1.2	1,160		0.009	0.09
H-39	2.9	230	5.9	0.09	0.87		SI
H-8317	0.7	550	5.7	0.2	0.2		NSI
H-8317	3.6	50	5.9	0.04	0.04	AZT	SI
	Mean (^*) early			0.08 (0.07)	0.51 (0.50)
	Mean (^*) late			0.09 (0.06)	0.32 (0.37)
Control 1				0.2	0.2
Control 2				0.13	0.13
Control 3				0.009	0.09
	Mean (^*)			0.11 (0.09)	0.14 (0.06)

Abbreviation: ND, not determined; NSI, (non)syncytium-inducing variant.

Standard deviation.